BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26538247)

  • 1. Visceral adiposity is associated with altered myocardial glucose uptake measured by (18)FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes.
    Kim G; Jo K; Kim KJ; Lee YH; Han E; Yoon HJ; Wang HJ; Kang ES; Yun M
    Cardiovasc Diabetol; 2015 Nov; 14():148. PubMed ID: 26538247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus.
    Kodama N; Tahara N; Tahara A; Honda A; Nitta Y; Mizoguchi M; Kaida H; Ishibashi M; Abe T; Ikeda H; Narula J; Fukumoto Y; Yamagishi S; Imaizumi T
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4438-45. PubMed ID: 24030946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic and type 2 diabetic subjects.
    Succurro E; Vizza P; Cicone F; Cassano V; Massimino M; Giofrè F; Fiorentino TV; Perticone M; Sciacqua A; Guzzi PH; Veltri P; Andreozzi F; Cascini GL; Sesti G
    Cardiovasc Diabetol; 2024 Apr; 23(1):144. PubMed ID: 38671460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors.
    Reijrink M; de Boer SA; Spoor DS; Lefrandt JD; Lambers Heerspink HJ; Boellaard R; Greuter MJ; Borra RJH; Hillebrands JL; Slart RHJA; Mulder DJ
    Atherosclerosis; 2019 Nov; 290():87-93. PubMed ID: 31604171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by
    Hu L; Shao X; Qiu C; Shao X; Wang X; Niu R; Wang Y
    BMC Endocr Disord; 2020 May; 20(1):75. PubMed ID: 32460891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Activity in the Visceral and Subcutaneous Adipose Tissues by FDG-PET/CT in Obese Patients.
    Monteiro AM; Ferreira G; Duarte H
    Acta Med Port; 2017 Nov; 30(11):813-817. PubMed ID: 29279074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral fat obesity increases serum DPP-4 levels in men with type 2 diabetes mellitus.
    Tanaka S; Kanazawa I; Notsu M; Sugimoto T
    Diabetes Res Clin Pract; 2016 Jun; 116():1-6. PubMed ID: 27321309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
    Kobayashi Y; Kumita S; Fukushima Y; Ishihara K; Suda M; Sakurai M
    J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by
    Rivers JP; Powell-Wiley TM; Dey AK; Rodante JA; Chung JH; Joshi AA; Natarajan B; Sajja AP; Chaturvedi A; Rana A; Harrington CL; Teague HL; Lockshin BN; Ahlman MA; Yao J; Playford MP; Gelfand JM; Mehta NN
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):349-357. PubMed ID: 29055628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging.
    Christen T; Sheikine Y; Rocha VZ; Hurwitz S; Goldfine AB; Di Carli M; Libby P
    JACC Cardiovasc Imaging; 2010 Aug; 3(8):843-51. PubMed ID: 20705265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
    J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based
    Hu L; Qiu C; Wang X; Xu M; Shao X; Wang Y
    BMC Cardiovasc Disord; 2018 Oct; 18(1):203. PubMed ID: 30373519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.
    Mather KJ; Hutchins GD; Perry K; Territo W; Chisholm R; Acton A; Glick-Wilson B; Considine RV; Moberly S; DeGrado TR
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E452-60. PubMed ID: 26732686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans.
    Labbé SM; Grenier-Larouche T; Noll C; Phoenix S; Guérin B; Turcotte EE; Carpentier AC
    Diabetes; 2012 Nov; 61(11):2701-10. PubMed ID: 23093657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by
    Tang K; Zheng X; Lin J; Zheng M; Lin H; Li T; Wang L
    J Nucl Cardiol; 2020 Oct; 27(5):1679-1688. PubMed ID: 30238301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the degree of abdominal myosteatosis by magnetic resonance imaging in subjects with diabetes, prediabetes and healthy controls from the general population.
    Kiefer LS; Fabian J; Rospleszcz S; Lorbeer R; Machann J; Storz C; Kraus MS; Schlett CL; Roemer F; Wintermeyer E; Rathmann W; Nikolaou K; Peters A; Bamberg F
    Eur J Radiol; 2018 Aug; 105():261-268. PubMed ID: 30017292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial.
    Heiskanen MA; Motiani KK; Mari A; Saunavaara V; Eskelinen JJ; Virtanen KA; Koivumäki M; Löyttyniemi E; Nuutila P; Kalliokoski KK; Hannukainen JC
    Diabetologia; 2018 Aug; 61(8):1817-1828. PubMed ID: 29717337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study.
    Boersma GJ; Johansson E; Pereira MJ; Heurling K; Skrtic S; Lau J; Katsogiannos P; Panagiotou G; Lubberink M; Kullberg J; Ahlström H; Eriksson JW
    Horm Metab Res; 2018 Aug; 50(8):627-639. PubMed ID: 30001566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
    Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E
    Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral and subcutaneous adipose tissue FDG uptake by PET/CT in metabolically healthy obese subjects.
    Oliveira AL; Azevedo DC; Bredella MA; Stanley TL; Torriani M
    Obesity (Silver Spring); 2015 Feb; 23(2):286-9. PubMed ID: 25522219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.